课题基金 / 基金详情

Development and Implementation of a Parks Prescription Intervention for Diabetes Prevention (PARK-DPRx)

Development and Implementation of a Parks Prescription Intervention for Diabetes Prevention (PARK-DPRx)
Parks 糖尿病预防处方干预措施 (PARK-DPRx) 的开发和实施
批准号:
480202
负责人:
Booth Gillian L
金额:
$65.76万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2023
资助国家:
加拿大
项目状态:
未结题
起止时间:
2023-03-01 至 2028-03-01

项目摘要

项目成果

Booth Gillian L的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The World Health Organization has outlined a new vision for primary care that integrates public health measures to promote health and wellbeing and community engagement.1,2 These recommendations call for novel, 'whole-of-society' solutions for preventing
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Impact of the COVID-19 Pandemic on Type 2 Diabetes Incidence: Finding synergy among science, policy, and action
  • 批准号:
    456910
  • 项目类别:
    Operating Grants
  • 资助金额:
    $7.29万
  • 财政年份:
    2021
  • 负责人:
    Booth Gillian L
  • 依托单位:
Development and Implementation of a Parks Prescription Intervention for Diabetes Prevention (PARKS-DP)
  • 批准号:
    459768
  • 项目类别:
    Operating Grants
  • 资助金额:
    $1.82万
  • 财政年份:
    2021
  • 负责人:
    Booth Gillian L
  • 依托单位:
Canada Research Chairs - Tier 1
  • 批准号:
    424773
  • 项目类别:
  • 资助金额:
    $101.99万
  • 财政年份:
    2019
  • 负责人:
    Booth Gillian L
  • 依托单位:
Evaluating Innovative Health Care Solutions to Improve Outcomes for Persons with Type 1 Diabetes using a Novel Electronic Data Repository
  • 批准号:
    378078
  • 项目类别:
    Operating Grants
  • 资助金额:
    $109.28万
  • 财政年份:
    2017
  • 负责人:
    Booth Gillian L
  • 依托单位:
海外基金